QSS
CPRX

Quantitative Systematic Strategies’s Catalyst Pharmaceutical CPRX Stock Holding History

Quantitative Systematic Strategies’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,104
Closed -$60K – 507
2021
Q1 		$60K Sell
13,104
-3,326
-20% -$13.2K 0.01% 590
2020
Q4 		$55K Sell
16,430
-4,106
-20% -$13.8K 0.01% 591
2020
Q3 		$61K Buy
+20,536
New +$80.3K 0.01% 571
2016
Q1 		– Sell
-41,502
Closed -$105K – 489
2015
Q4 		$105K Buy
+41,502
New +$119K 0.03% 864

Other funds holding CPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quantitative Systematic Strategies's CPRX Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of Catalyst Pharmaceutical (CPRX) in Q2 2021, closing a stake of 13,104 shares — an estimated $60K sold.

Quantitative Systematic Strategies first reported a position in CPRX in Q4 2015 and held it in 4 quarters. The position peaked at $105K in Q4 2015. 139 funds tracked by Wall St. Rank hold CPRX as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining Catalyst Pharmaceutical position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 13,104 Catalyst Pharmaceutical shares in Q2 2021, an estimated $60K.
  • Quantitative Systematic Strategies first reported a position in Catalyst Pharmaceutical in Q4 2015 and held it in 4 quarters.
  • Quantitative Systematic Strategies's Catalyst Pharmaceutical position peaked at $105K in Q4 2015.
  • 139 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.